---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-049999"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:37:10.940145+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# BriaCell closes $5.55M public offering of 7.4M units at $0.75/unit

## Summary
- Underwritten public offering of 7,400,000 units closed Dec 13, 2024; gross proceeds $5.55M.
- Each unit: 1 common share + 1 warrant exercisable at $0.9375 for 5 years.
- Underwriter ThinkEquity received 370,000 representative's warrants on same terms.
- Net proceeds to be used for working capital, general corporate purposes, and business advancement.
- Offering made under effective shelf registration statement (S-3 No. 333-276650).

## SEC filing metadata
- accession: 0001493152-24-049999
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315224049999/0001493152-24-049999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224049999/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-049999
- JSON: https://secwatch.observer/filing/0001493152-24-049999.json
- Plain text: https://secwatch.observer/filing/0001493152-24-049999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.